All News

Medicare keeping limits on anemia drugs

Genetic differences predict anti-inflammatory benefits from nutritional products

Shop 'n Save Pharmacy to provide Vitality Check wellness service

NACDS Foundation Chain Pharmacy Industry Profile highlights role of pharmacists

College of Pharmacy gets new home

NACDS debunks New York Times article, "The 'Poisonous Cocktail' of Multiple Drugs"

Inflated average wholesale prices issued by two publishers have resulted in high costs for consumers, who have filed class-action suits against them.

Oripavine is designated a Schedule II controlled substance by the Drug Enforcement Administration

National Quality Forum releases standards for substance abuse treatment

TWC Global issues recall of Axcil and Desirin

NCCN updates its dermatofibrosarcoma protuberans guidelines.

NCCN updates hepatobiliary cancer treatment guidelines.

ASHP launches on-line resource center

CMS outlines plans for contacting low-income subsidy beneficiaries for Medicare Part D program.

CVS/pharmacy to offer flu vaccinations in over 4,000 stores.

FDA warns about risk of Cryptosporidium illness from Baby's Bliss Gripe Water

Pharmacy owner pleads guilty to charges stemming from Affpower Internet pharmacy.

Hospitals swallowing cost of errors

Campath granted regular approval

New study results released for once-yearly Reclast (zoledronic acid) injection

Valeant Pharmaceuticals offers zelaCARD rebate program to Parkinson's disease patients.

Americans confident about drug safety

Personalized medicine report issued by HHS

Study from AHRQ and FDA will examine cardiovascular risks of ADHD drugs.

A PhRMA-sponsored study claims Medicare Part D reduced expenses for beneficiaries who had no insurance prior to the program.

NACDS testifies to Senate on methamphetamine

Although FDA is not aware of significant health risks, the agency is concerned about some of the product's claims.

More than 70 pharmacy executives and representatives visited with members of Congress.